| [1] |
Pepi M, Evangelista A, Nihoyannopoulos P, et al. Recommendations for echocardiography use in the diagnosis and management of cardiac sources of embolism: European Association of Echocardiography (EAE) (a registered branch of the ESC)[J]. Eur J Echocardiogr, 2010, 11(6):461-476.
|
| [2] |
Chen X, Luo W, Li J, et al. Diagnostic accuracy of STAF, LADS, and iPAB scores for predicting paroxysmal atrial fibrillation in patients with acute cerebral infarction[J]. Clin Cardiol, 2018, 41(12):1507-1512.
|
| [3] |
Suissa L, Bertora D, Lachaud S, et al. Score for the targeting of atrial fibrillation (STAF): a new approach to the detection of atrial fibrillation in the secondary prevention of ischemic stroke[J]. Stroke, 2009, 40(8):2866-2868.
|
| [4] |
Alves M, Narciso MR, Cruz J, et al. Paroxysmal atrial fibrillation detection in patients with acute ischemic stroke through prolonged Holter: prospective study[J]. Aging Clin Exp Res, 2019, 31(4):469-474.
|
| [5] |
Hannon N, Sheehan O, Kelly L, et al. Stroke associated with atrial fibrillation--incidence and early outcomes in the north Dublin population stroke study[J]. Cerebrovasc Dis, 2010, 29(1):43-49.
|
| [6] |
Arboix A, Cendrós V, Besa M, et al. Trends in risk factors, stroke subtypes and outcome. Nineteen-year data from the Sagrat Cor Hospital of Barcelona stroke registry[J]. Cerebrovasc Dis, 2008, 26(5):509-516.
|
| [7] |
Freedman B, Potpara TS, Lip GY. Stroke prevention in atrial fibrillation[J]. Lancet, 2016, 388(10046):806-817.
|
| [8] |
Saber H, Thrift AG, Kapral MK, et al. Incidence, recurrence, and long-term survival of ischemic stroke subtypes: a population-based study in the Middle East[J]. Int J Stroke, 2017, 12(8):835-843.
|
| [9] |
Kolominsky-Rabas PL, Weber M, Gefeller O, et al. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study[J]. Stroke, 2001, 32(12):2735-2740.
|
| [10] |
Jain V, Marshall IJ, Crichton SL, et al. Trends in the prevalence and management of pre-stroke atrial fibrillation, the South London stroke register, 1995-2014. PLoS One. 2017;12(4):e0175980.
|
| [11] |
Liao J, Khalid Z, Scallan C, et al. Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review[J]. Stroke, 2007, 38(11):2935-2940.
|
| [12] |
Rizos T, Güntner J, Jenetzky E, et al. Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke[J]. Stroke, 2012, 43(10):2689-2694.
|
| [13] |
Elijovich L, Josephson SA, Fung GL, et al. Intermittent atrial fibrillation may account for a large proportion of otherwise cryptogenic stroke: a study of 30-day cardiac event monitors[J]. J Stroke Cerebrovasc Dis, 2009, 18(3):185-189.
|
| [14] |
Arboix A. Cardiovascular risk factors for acute stroke: Risk profiles in the different subtypes of ischemic stroke[J]. World J Clin Cases, 2015, 3(5):418-429.
|
| [15] |
Chen CY, , Lin PT, , Wang YH, et al. Etiology and risk factors of intracranial hemorrhage and ischemic stroke in young adults. J Chin Med Assoc. 2021;84(10):930-936.
|
| [16] |
Vitolo M, Imberti JF, Maisano A, et al. Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis[J]. Eur J Intern Med, 2021, 92:100-106.
|
| [17] |
Neubeck L, Orchard J, Lowres N, et al. To screen or not to screen? Examining the arguments against screening for atrial fibrillation[J]. Heart Lung Circ, 2017, 26(9):880-886.
|
| [18] |
Svennberg E, Engdahl J. Why should we screen for atrial fibrillation?[J]. Heart, 2017, 103(1):6-7.
|
| [19] |
United Kingdom National Screening Committee. The UK NSC recommendation on atrial fibrillation screening in adults.(2014-01-27)
URL
|
| [20] |
Brambatti M, Connolly SJ, Gold MR, et al. Temporal relationship between subclinical atrial fibrillation and embolic events[J]. Circulation, 2014, 129(21):2094-2099.
|
| [21] |
Daoud EG, Glotzer TV, Wyse DG, et al. Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS[J]. Heart Rhythm, 2011, 8(9):1416-1423.
|
| [22] |
Lau CP, Siu CW, Yiu KH, et al. Subclinical atrial fibrillation and stroke: insights from continuous monitoring by implanted cardiac electronic devices[J]. Europace, 2015, 17 Suppl 2:ii40-46.
|
| [23] |
Boriani G, Laroche C, Diemberger I, et al. Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry[J]. Am J Med, 2015, 128(5):509-518.e2.
|
| [24] |
Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke[J]. N Engl J Med, 2012, 366(2):120-129.
|
| [25] |
Hess PL, Healey JS, Granger CB, et al. The role of cardiovascular implantable electronic devices in the detection and treatment of subclinical atrial fibrillation: a review[J]. JAMA Cardiol, 2017, 2(3):324-331.
|
| [26] |
Van Gelder IC, Healey JS, Crijns H, et al. Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT[J]. Eur Heart J, 2017, 38(17):1339-1344.
|
| [27] |
Schnabel RB, Haeusler KG, Healey JS, et al. Searching for atrial fibrillation poststroke: a white paper of the AF-SCREEN International Collaboration[J]. Circulation, 2019, 140(22):1834-1850.
|
| [28] |
Orchard JJ, Neubeck L, Freedman B, et al. Atrial fibrillation screen, management and guideline recommended therapy (AF SMART II) in the rural primary care setting: an implementation study protocol[J]. BMJ Open, 2018, 8(10):e023130.
|
| [29] |
Stahrenberg R, Weber-Krüger M, Seegers J, et al. Enhanced detection of paroxysmal atrial fibrillation by early and prolonged continuous holter monitoring in patients with cerebral ischemia presenting in sinus rhythm[J]. Stroke, 2010, 41(12):2884-2888.
|
| [30] |
Ziegler PD, Rogers JD, Ferreira SW, et al. Real world experience with insertable cardiac monitors to find atrial fibrillation in cryptogenic stroke[J]. Cerebrovasc Dis, 2015, 40(3-4):175-181.
|
| [31] |
Perino AC, Gummidipundi SE, Lee J, et al. Arrhythmias other than atrial fibrillation in those with an irregular pulse detected with a Smartwatch: findings from the Apple Heart study[J]. Circ Arrhythm Electrophysiol, 2021, 14(10):e010063.
|
| [32] |
Guo Y, Liu T, Chen Y, et al. Reply: Observations from the Huawei Heart study using photoplethysmography-based smart devices for atrial fibrillation screening[J]. J Am Coll Cardiol, 2020, 75(11):1366-1367.
|
| [33] |
Takizawa S. Response to "Geotopographic and environmental characteristics of communities and the seasonality of stroke occurrences" (published in J Stroke Cerebrovasc Dis, Volume 22, issue 3, 2013, 279-280)[J]. J Stroke Cerebrovasc Dis, 2013, 22(8):1436-1437.
|
| [34] |
Purmah Y, Tull S, Neculau G, et al. P2639Elevated levels of BNP and fibroblast growth factor 23 in patients with atrial fibrillation: an analysis of 40 cardiovascular biomarkers in 667 unselected hospitalized patients[J]. Euro Heart J, 2017(suppl_1): 561-562.
|
| [35] |
Best JG, Bell R, Haque M, et al. Atrial fibrillation and stroke: a practical guide[J]. Pract Neurol, 2019, 19(3):208-224.
|
| [36] |
Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC [J]. Eur Heart J, 2021, 42(5):373-498.
|
| [37] |
Halcox J, Wareham K, Cardew A, et al. Assessment of Remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation: The REHEARSE-AF study[J]. Circulation, 2017, 136(19):1784-1794.
|